From our November 1 issue: With sprayable probes, theranostic nanoprobes, and other novel biomarkers at their command, clinical users of MRI, PET, and SPECT may image more incisively. Researchers are ...

Contemporary PET imaging has transitioned from a metabolic approach largely dominated by [¹⁸F]FDG to a multifaceted molecular platform encompassing a ...

Seeing chemistry unfold inside living cells is one of the biggest challenges of modern bioimaging. Raman microscopy offers a powerful way to meet this challenge by reading the unique vibrational ...

Cancer is a universal issue which affects many people around the world. Many will turn to surgery in the hope a surgeon will ...

Scientists at the Massachusetts General Hospital (MGH) have developed a molecular imaging probe to reveal Alzheimer's disease (AD)-related γ-secretase in rodents and macaques with translational ...

The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail. Researchers at Memorial ...

Successful cancer surgery depends on a surgeon’s ability to remove tumors, while minimizing harm to healthy tissues. Surgeons currently use glowing dyes which mark cancer cells to help differentiate ...

Breast cancer makes up a large fraction of newly diagnosed cancer cases in the US. About 42% of breast cancer patients choose to undergo a lumpectomy or breast-conserving surgery (BCS) as opposed to ...

A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia. Targeting the olfactory nerve, the new tool has potential to ...